The Stanford–Santa Clara County Methamphetamine Task Force

  • Lawrence McGlynnEmail author


Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) is a disease with immunological and neuropsychiatric implications including depression, fatigue, and cognitive dysfunction. Significant social factors such as poverty, stigma, and rejection are also frequently encountered. Further complicating the picture, substance abuse in HIV/AIDS is not uncommon, affecting not only the patient but also the health and well-being of the community. Methamphetamine has been a major challenge in many western states, and its link to HIV/AIDS is well documented, both as a risk factor for infection and a contributor to morbidity in those already infected. The Stanford–Santa Clara County Methamphetamine Task Force was founded in 2004 by providers on the frontline to address this complex problem.


Human Immunodeficiency Virus (HIV) Acquired Immune Deficiency Syndrome (AIDS) Methamphetamine Neuropsychiatry Neurocognitive disorders Public health Community psychiatry 


  1. 1.
    Foucault M. Madness and civilization: a history of insanity in the Age of Reason. s.l. New York: Pantheon Books; 1964.Google Scholar
  2. 2.
    Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 2010;22:630–9.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Bazell R (Reporter), Brokaw T (Anchor). Early studies on AIDS. NBC Nightly News, June 17, 1982. Available at Last accessed 23 Feb 2015.
  4. 4.
    Darnell A, Nance K (Writers), Machine (Performer). There but for the grace of God go I. New York: RCA Victor, 1979.Google Scholar
  5. 5.
    Boynton A. Remembering St. Vincent’s. The New Yorker, May 17, 2013. Available at Last accessed 23 Feb 2015.
  6. 6.
    France D. Holding AIDS at bay, only to face ‘Lazarus Syndrome.’ The New York Times, October 6, 1998. Available at Last accessed 23 Feb 2015.
  7. 7.
    O’Brien Q. Methamphetamine use by HIV-positive men. National HIV Prevention Conference. Atlanta: Centers for Disease Control, 2005.Google Scholar
  8. 8.
    Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health. 2005;82:i62–70.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Markowitz JC, Kocsis JH, Fishman B, Spielman LA, Jacobsberg LB, Frances AJ. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry. 1998;55:452–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Chang L, Ernst T, Speck O, Grob CS. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005;162:361–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Yudko E, Murray-Bridges L, Watson-Hauanio S. History of methamphetamine. In: Yudko E, Hall HV, McPherson SB, editors. Methamphetamine use: clinical and forensic aspects. Boca Raton, FL: CRC; 2003. p. 4–10.CrossRefGoogle Scholar
  12. 12.
    Department of Alcohol and Drug Services. Treatment admissions and discharges: adult system of care, FY 2003. San Jose, CA: Santa Clara County; 2003.Google Scholar
  13. 13.
    National Institute of Justice. Arrestee Drug Abuse Monitoring Program. Washington DC, National Institute of Justice, 2003.Google Scholar
  14. 14.
    Webster's New Collegiate Dictionary 8th Edition. 1976.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Psychiatry and Behavioral SciencesStanford University School of MedicineStanfordUSA

Personalised recommendations